Zambon Acquires Breath Therapeutics for Up-to-€500M, Adding to Respiratory Pipeline - Genetic Engineering & Biotechnology News
Zambon Acquires Breath Therapeutics for Up-to-€500M, Adding to Respiratory Pipeline Genetic Engineering & Biotechnology News
Italian pharma Zambon said today it has acquired Breath Therapeutics and its subsidiaries for up to €500 million (about $559 million), in a deal that adds a ...
Comments
Post a Comment